Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2

References

• Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198(7):962–70. Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness (nih.gov). doi:10.1086/591708.
   PubMed Web of Science ®Google Scholar
• Al-Osail AM, Al-Wazzah MJ. The history and epidemiology of Middle East Respiratory Syndrome corona virus. Multidiscip Respir Med. 2017;12:20. https://mrmjournal.biomedcentral.com/articles/10.1186/s40248-017-0101-8 .
   PubMed Web of Science ®Google Scholar
• Golda A, Malek N, Dudek B, Zeglen S, Wojarski J, Ochman M, Kucewicz ZM, Potempa J, Pyrc K. Infection with human coronavirus NL63 enhances streptococcal adherence to epithelial cells. J Gen Virol. 2011;92(Pt6):1358–68. doi:10.1099/vir.0.028381-0.
   PubMedGoogle Scholar
• Wong SCY, Kwong RT-S, Wu TC, Chan JWM, Chu MY, Lee SY, Wong HY, Lung DC. Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong. J Hosp Infect. 2020;105(2):119–27. doi:10.1016/j.jhin.2020.03.036.
   PubMed Web of Science ®Google Scholar
• Thindwa D, Quesada MG, Liu Y, Bennett J, Cohen C, Knoll MD, von Gottberg A, Hayford K, Flasche S Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality (non-peer-reviewed). Centre for Mathematical Modelling of Infectious Diseases published on-line 25 April 2020 [accessed 2020 Sep 3]. https://cmmid.github.io/topics/covid19/covid19_siv_ppv23.html
   Google Scholar
• Rickman HM, Rampling T, Shaw K, Martinez-Garcia G, Hail L, Coen P, Shahmanesh M, Shin GY, Nastouli E, Houlihan CF. Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital. Clin Infect Dis published on-line. 2020 Jun 20. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa816/5860253
   Web of Science ®Google Scholar
• Zhou Q, Gao Y, Wang X, Liu R, Du P, Wang X, Zhang X, Lu S, Wang Z, Shi Q, et al. Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis. Ann Trans Med. 8(10):2020. http://atm.amegroups.com/article/view/42877/html
   Web of Science ®Google Scholar
• Rhee C, Baker M, Vaidya V, Tucker R, Resnick A, Ca M, Klompas M. for the CDC prevention epicenters program. Incidence of nosocomial COVID-19 in patients hospitalized at a large US academic medical center. JAMA Network Open. 2020;3(9):e2020498. doi:10.1001/jamanetworkopen.2020.20498.
   PubMed Web of Science ®Google Scholar
• Khonyongwa K, Taori SK, Soares A, Desai N, Sudhanva M, Bernal W, Schelenz S, Curran LA. Incidence and outcomes of healthcare-associated COVID-19 infections: significance of delayed diagnosis and correlation with staff absence. J Hosp Infect. 2020;106:663–72. doi:10.1016/j.jhin.2020.10.006.
   PubMed Web of Science ®Google Scholar
• Correa-Martínez CL, Schwierzeck V, Mellmann A, Hennies M, Kampmeier S. Healthcare-associated SARS-CoV-2 transmission – experiences from a German University Hospital. Microorganisms. 2020;8(9):1378. doi:10.3390/microorganisms8091378.
   Web of Science ®Google Scholar
• Sikkema RS, Pas SD, Nieuwenhuijse DF, Á O, Verweij J, Van Der Linden A. COVID-19 in health-care workers in three hospitals in the south of The Netherlands: a cross-sectional study. Lancet Infect Dis. 2020;20(11):1273–80. COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study (nih.gov). doi:10.1016/S1473-3099(20)30527-2.
   PubMed Web of Science ®Google Scholar
• Ma L, Wang W, Le Grange JM, Wang X, Du S, Li C, Wei J, Zhang J-N. Coinfection of SARS-CoV-2 and other respiratory pathogens. Infect Drug Resist. 2020;2020:3045–53. doi:10.2147/IDR.S267238.
   Google Scholar
• Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens (letter). JAMA. published on-line. 2020 Apr 15;323(20):2085. doi: 10.1001/jama.2020.6266
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020 March 11;395(10229):1054–62. published on-line. doi: 10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–75. doi:10.1016/j.jinf.2020.05.046.
   PubMed Web of Science ®Google Scholar
• Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy J-P, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. published online. 2020 July 22;26(12):1622–29. doi: 10.1016/j.cmi.2020.07.016
   PubMed Web of Science ®Google Scholar
• Sohal S, Rodriguez-Nava G, Khabbaz R, Chaudry S, Musurakis C, Chitraka S, Chundi VV, Friedman HJ. SARS-CoV-2 and co-infections: a review of two cases. Case Rep Infect Dis. 2020:article ID 8882348. https://www.hindawi.com/journals/criid/2020/8882348/ .
   Web of Science ®Google Scholar
• Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE. Co-infection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus/enterovirus? J Med Virol. 2020 April 30;92(10):1699–700. doi:10.1002/jmv.25953.
   PubMed Web of Science ®Google Scholar
• Stowe J, Tessier E, Zhao H, Guy R, Muller-Pebody B, Zambon M, Andrews N, Ramsay M, Lopez Bernal J. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. Int J Epidemiol published on-line. 22 Sept 2020. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design | International Journal of Epidemiology | Oxford Academic (oup.com). doi:10.1093/ije/dyab081
   Web of Science ®Google Scholar
• Ozaras R, Cirpin R, Duran A, Duman H, Arslan O, Bakcan Y, Kaya M, Mutlu H, Isayeva L, Kebanlı F, et al. Influenza and COVID-19 coinfection: report of six cases and review of the literature. J Med Virol 2020 Jun 4;92(11):2657–65. published online. Influenza and COVID‐19 coinfection: Report of six cases and review of the literature - Ozaras - 2020 - Journal of Medical Virology - Wiley Online Library. doi: 10.1002/jmv.26125
   PubMed Web of Science ®Google Scholar
• Amin-Chowdhury Z, Aiano F, Mensah A, Sheppard C, Litt D, Fry NK, Andrews N, Ramsay ME, Ladhani SN. Impact of the COVID-19 pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with SARS-CoV-2: prospective national cohort study, England. Clin Infect Dis ciaa1728 published on-line. 16 Nov 2020. Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection with SARS-CoV-2: prospective national cohort study, England | Clinical Infectious Diseases | Oxford Academic (oup.com). March 2021;72(5):e65–e75.
   PubMed Web of Science ®Google Scholar
• Houseman C, Chapman KE, Manley P, Gorton R, Wilson D, Hughes GJ. Decreasing case fatality rate following invasive pneumococcal disease, North East England, 2006-2016. Epidemiol Infect. 2019;147:e175. Decreasing case fatality rate following invasive pneumococcal disease, North East England, 2006–2016 (nih.gov). doi:10.1017/S0950268819000657.
   PubMed Web of Science ®Google Scholar
• Contou D, Claudinon A, Pajot O, Micaëlo M, Longuet Flandre P, Dubert M, Cally R, Logre E, Fraissé M, Mentec H, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care published on-line. 7 September 2020;10. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU | Annals of Intensive Care | Full Text (springeropen.com). doi: 10.1186/s13613-020-00736-x
   Web of Science ®Google Scholar
• Naito T, Suzuki M, Kanazawa A, Takahashi H, Fujibayashi K, Yokokawa H, Kuwatsuru R, Watanabe A. Pneumococcal vaccination reduces in-hospital mortality, length of stay and medical expenditure in hospitalized elderly patients. J Infect Chemother. 2020;26(7):715–21. doi:10.1016/j.jiac.2020.03.016.
   PubMed Web of Science ®Google Scholar
• Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J. Reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis. 2006;42(8):1093–101. doi:10.1086/501354.
   PubMed Web of Science ®Google Scholar
• Domínguez A, Izquierdo C, Salleras L, Ruiz L, Sousa D, Bayas J-M, Benot M, Varona W, Celorrio J-M, Carratalà J. For the working group for the study of prevention of CAP in the elderly. Eur Res J. 2010;36:608–14. https://erj.ersjournals.com/content/36/3/608 .
   PubMed Web of Science ®Google Scholar
• Noale M, Trevisan C, Maggi S, Incalzi RA, Pedone C, Di Bari M, Adorni F, Jesuthasan N, Sojic A, Galli M, et al., on behalf of the EPICOVID19 Working Group. The association between influenza and pneumococcal vaccinations and SARS-CoV-2 infection: data from the EPICOVID19 web-based survey. Vacc MDPI. 2020;8(3):471. doi: 10.3390/vaccines8030471
   PubMed Web of Science ®Google Scholar
• Conlon A, Ashur C, Washer L, Eagle KA, Hofmann Bowman MA. Impact of the influenza vaccine on COVID-19 infection rates and severity. Am J Infect Control published on-line. 22 Feb 2021;49(6):694–700. Impact of the influenza vaccine on COVID-19 infection rates and severity - American Journal of Infection Control (ajicjournal.org). doi: 10.1016/j.ajic.2021.02.012
   PubMed Web of Science ®Google Scholar
• Subbarao K, Mahanty S. Respiratory virus infections: understanding COVID-19. Immunity. 2020;52(6):905–09. Respiratory Virus Infections: Understanding COVID-19 (nih.gov). doi:10.1016/j.immuni.2020.05.004.
   PubMed Web of Science ®Google Scholar
• Salem ML, El-Hennawy D. The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19. Med Hypotheses. 2020;140:109752. The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19 (nih.gov). doi:10.1016/j.mehy.2020.109752.
   PubMed Web of Science ®Google Scholar
• Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Fasce Pineda R, Cohen C, Fry AM. Decreased influenza activity during the COVID-19 pandemic – United States, Australia, Chile, and South Africa, 2020. Morbidity Mort Weekly Rep. 2020;69(37):1305–09. Decreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020 | MMWR (cdc.gov). doi:10.15585/mmwr.mm6937a6.
   PubMed Web of Science ®Google Scholar
• Anton-Vazques V, Clivillé R. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19. Eur J Clin Microbiol Infect Dis. 2021;40:1353–55. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19 (springer.com). doi:10.1007/s10096-021-04166-w.
   PubMed Web of Science ®Google Scholar
• Root-Bernstein R. Possible cross-reactivity between SARS-CoV-2 proteins, CRM197 and proteins in pneumococcal vaccines may protect against symptomatic SARS-CoV-2 disease and death. Vacc MDPI. 2020;8(4):559. doi:10.3390/vaccines8040559.
   Web of Science ®Google Scholar
• Dyda A, Karki S, Hayen A, MacIntyre CR, Menzies R, Banks E, Kaldor JM, Liu B. Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake. BMC Infect Dis. 2016;16. article number 515. Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake | BMC Infectious Diseases | Full Text (biomedcentral.com). doi: 10.1186/s12879-016-1820-8
   PubMed Web of Science ®Google Scholar